Sphera Funds Management Ltd. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $363 Million distributed in 111 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $27.2M, Nova Ltd. with a value of $20.9M, Syndax Pharmaceuticals Inc with a value of $14.7M, Tower Semiconductor LTD with a value of $11.5M, and Cytokinetics Inc with a value of $10.8M.

Examining the 13F form we can see an decrease of $16.6M in the current position value, from $380M to 363M.

Sphera Funds Management Ltd. is based out at Tel Aviv, L3

Below you can find more details about Sphera Funds Management Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $363 Million
Healthcare: $246 Million
Technology: $72.8 Million
ETFs: $20.7 Million
Consumer Cyclical: $7.12 Million
Utilities: $6.53 Million
Communication Services: $6.29 Million
Industrials: $2.7 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 111
  • Current Value $363 Million
  • Prior Value $380 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 16 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 53 stocks
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.